CRISPR Therapy for SCN2A Epilepsy: What the Research Shows
Researchers studied a genetic condition called SCN2A haploinsufficiency, which is linked to neurodevelopmental disorders like autism and epilepsy.
Pediatrics
This hub covers pediatric epilepsy in infants, kids, and teens, including diagnosis, syndromes, development, school plans, and safety. New studies translated into clear takeaways for parents.
What you’ll find in this topic:
- Plain-language summaries of new epilepsy studies
- What the research means for real life
- Practical questions to ask your neurologist
- Related topics you can explore next
Pediatrics: What Families Usually Want to Know
- What’s different about epilepsy in infants, kids, and teens
- Common causes, including genetic syndromes and brain development issues
- When to push for a specialty epilepsy center
- School plans, sports, and day-to-day safety
Common Pediatric Epilepsy Terms in Plain English
- Syndrome: A recognizable pattern of seizures + EEG + symptoms
- Developmental delay: Slower skill development (can have many causes)
- Regression: Losing previously gained skills (flag for urgent evaluation)
- Febrile seizure: Seizure with fever (often benign, sometimes relevant)
- Epileptic encephalopathy: Seizures/EEG patterns that can affect development
Related Topics
Pediatric Epilepsy FAQ
When is epilepsy “drug-resistant?”
Usually when two appropriate medications haven’t controlled seizures.
Should we get a 504 plan or an IEP?
Many families benefit and it depends on seizure frequency, medications, and learning needs.
Can kids with epilepsy play sports?
Often yes, with smart precautions. Ask your neurologist or epileptologist about your child’s specific risks.
What symptoms mean “call now?”
Clusters, prolonged seizures, breathing trouble, new weakness, or major regression.
-
-
Lacosamide May Trigger New Seizure Type in Children
Researchers studied the effects of a medication called lacosamide (LCM) in three young patients with epilepsy.
-
Devices & Neuromodulation | Epilepsy Research Summaries | Genetics | New Studies | Pediatrics | Pregnancy
New Insights on Treating Infantile Epilepsy Spasms Syndrome
Researchers studied infantile epilepsy spasms syndrome (IESS), a serious condition that affects about 3 in 10,000 newborns in the U.S.
-
New Medications Show Promise for Lennox-Gastaut Syndrome Care
Researchers studied the effectiveness of five newer anti-seizure medications (ASMs) in treating Lennox-Gastaut syndrome (LGS), a severe form of epilepsy that begins in childhood and is often resistant to treatment.
-
Comorbidities | Drug-Resistant Epilepsy | Epilepsy Research Summaries | New Studies | Pediatrics | Status Epilepticus
Improving Quality of Life After Refractory Status Epilepticus
This study looked at the long-term quality of life for people who survived a severe type of epilepsy called new onset refractory status epilepticus (NORSE), including a specific form known as febrile infection-related epilepsy syndrome (FIRES).
-
Drug-Resistant Epilepsy | Epilepsy Research Summaries | New Studies | Pediatrics | Safety & First Aid
Epidyolex Safely Increases CBD Levels in Children with Epilepsy
This study looked at the blood levels of two substances, cannabidiol (CBD) and tetrahydrocannabinol (THC), in children with epilepsy that does not respond to standard treatments.
-
Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | Lifestyle & Sleep | New Studies | Pediatrics
New Drug Shows Promise for KCNT1 Epilepsy Treatment
Researchers studied a specific type of epilepsy linked to mutations in the KCNT1 gene, which causes potassium channels in the brain to become overly active.
-
New Method Improves Analysis of Long-Term Treatment Effects
Researchers studied how to analyze data from trials that look at the effects of treatments over time, specifically focusing on a method called Latent Change Models (LCMs).
-
Pyridoxine May Help Reduce Behavioral Issues in Kids on Levetiracetam
This study looked at how pyridoxine, also known as vitamin B6, might help reduce neuropsychiatric side effects caused by the epilepsy medication levetiracetam in children and adolescents.
